Vistagen Therapeutics, Inc. VTGN
0.18 USD 0.00 (-0.70%)
At closeNov 11, 2026, 4:36 AM EST
0.19 0.00 +1.64%
Pre-market · Nov 11, 4:36 AM ET
0.176 Day range 0.1879
0.16 52-week range 5.14
- YTD
- -72.26%
- 1 year
- -95.46%
News
benzinga.com Vistagen Intends To Adopt Incorporate Interim Assessments Of Fasedienol's Effect Through eDiaries, Qualitative Patient Surveys In Phase 3 Trial Design After Type C Meeting With FDA Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry, today announced a regulatory update from its recent, productive…
benzinga.com Vistagen Therapeutics Implements 31% Workforce Reduction On October 26, 2026; Workforce Reduction Expected To Save $3.20M In Salary And Benefits Annually On October 26, 2026, Vistagen Therapeutics, Inc. (the "Company") implemented a Board-approved reduction in workforce by approximately 31%, retaining core clinical, regulatory, technical, and corporate